Back to search

Article

Predicting response and resistance to immune checkpoint blockade and surgery in melanoma patients

2023-10-06

Abstract excerpt

Melanoma remains a formidable clinical challenge, claiming the lives of 60,000 patients annually. Current therapeutic modalities encompass surgical intervention and immune checkpoint inhibitors (ICB). Nevertheless, the efficacy of ICB varies, necessitating the need to anticipate response and resistance outcomes, while also considering alternative approaches, such as surgical interventions coupled with autologous s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8705491f-4778-5310-b12f-377c7b2f6455
DOI
10.1101/2023.10.05.23296626
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting response and resistance to immune checkpoint blockade and surgery in melanoma patientsDOI 10.1101/2023.10.05.23296626
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity
Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.Semantic proximity
Construction of immune scores to predict patient prognosis and response of anti-PD1 treatment in stage III-IV melanomaSemantic proximity
Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironmentSemantic proximity
Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma.Semantic proximity
Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden.Semantic proximity
Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.Semantic proximity
Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.Semantic proximity
The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesSemantic proximity
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios.Semantic proximity
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.Semantic proximity
Select a neighboring publication to make it the new centre.